Not Medicare Enrolled
Dr. Ronald Henry, MD
Urology Physician · Shenandoah, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Henry from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Henry?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Henry
Dr. Ronald Henry is an urology physician in Shenandoah, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Henry performed 3,411 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Henry received a total of $6,485 from 48 pharmaceutical and/or device companies across 262 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Henry is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 34% volume in TX
$6,485 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,411
Medicare services
Top 34% in TX for urology physician
Not available
Unique patients (not deduplicated)
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
845 | $34 | $71 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
531 | $3 | $18 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
325 | $34 | $71 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
289 | $58 | $177 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
261 | $77 | $250 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
236 | $7 | $20 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
214 | $8 | $12 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
165 | $69 | $140 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
65 | $34 | $72 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
65 | $34 | $72 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
65 | $34 | $71 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
65 | $34 | $71 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 60 | $135 | $695 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
55 | $34 | $71 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
52 | $0 | $15 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
43 | $167 | $483 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
32 | $10 | $28 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $79 | $326 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
15 | $26 | $65 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
11 | $104 | $405 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$6,485
Total received (2018-2024)
Avg $926/year across 7 years
Top 31% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
262
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$41
2023
$927
2022
$1,380
2021
$1,253
2020
$316
2019
$1,308
2018
$1,261
Payments by company (2024)
Sumitomo Pharma America, Inc.
$41
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$917
Janssen Biotech, Inc.
$782
PFIZER INC.
$680
Endo Pharmaceuticals Inc.
$378
Antares Pharma, Inc.
$323
Avadel Specialty Pharmaceuticals, LLC
$308
ABBVIE INC.
$291
Allergan Inc.
$240
Teleflex LLC
$179
Myriad Genetic Laboratories, Inc.
$165
Myovant Sciences Inc.
$152
COLOPLAST CORP
$149
Sumitomo Pharma America, Inc.
$143
AbbVie Inc.
$132
Novartis Pharmaceuticals Corporation
$124
AbbVie, Inc.
$111
UROGEN PHARMA, INC.
$110
UROVANT SCIENCES INC
$98
Axonics, Inc.
$98
Janssen Products, LP
$85
Olympus America Inc.
$74
Alnylam Pharmaceuticals Inc.
$74
MEDIVATION FIELD SOLUTIONS LLC
$71
Axonics Modulation Technologies, Inc.
$71
Allergan, Inc.
$66
C. R. Bard, Inc. & Subsidiaries
$63
C. R. BARD, INC. & SUBSIDIARIES
$59
Bayer HealthCare Pharmaceuticals Inc.
$51
Rochester Medical Corporation
$47
TherapeuticsMD, Inc.
$44
Supernus Pharmaceuticals, Inc.
$40
Dendreon Pharmaceuticals LLC
$36
PROCEPT BioRobotics Corporation
$27
Bayer Healthcare Pharmaceuticals Inc.
$26
Medtronic, Inc.
$25
Agiliti Surgical, Inc.
$24
Telix Pharmaceuticals
$24
Lantheus Medical Imaging, Inc.
$23
Tolmar, Inc.
$23
ConvaTec Inc.
$22
BOSTON SCIENTIFIC CORPORATION
$22
Retrophin, Inc.
$21
Boston Scientific Corporation
$19
Merck Sharp & Dohme LLC
$18
Hollister Incorporated
$17
Clarus Therapeutics Inc.
$13
Acerus Pharmaceuticals Corporation
$12
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 36.7% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM ROBOTIC SYSTEM · AVEED · AVYCAZ · Altis · Androgel · Axonics · Axonics r-SNM System · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · BRACANALYSIS CDX · BRACAnalysis CDx · Bard Urinary Drainage Bag · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL THERAPIES · GENERAL BPH · GENTLECATH · GILENYA · ILLUCCIX · IMVEXXY · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · OXLUMO · Olympus Cysto-Resection · Olympus Laser Devices · Onli · Otrexup · PROLARIS · PROVENGE · Quadramet · TLANDO · TOVIAZ · UroLift System · UroPass · XIAFLEX · XTANDI · XYOSTED · Xofigo · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
41
County median income
$97,266
Nearest hospital to ZIP centroid (approximate)
ST LUKE'S THE WOODLANDS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Henry is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Henry experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Henry performed 845 infectious disease dna/rna test services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Henry receive payments from pharmaceutical companies?
Yes. Dr. Henry received a total of $6,485 from 48 companies across 262 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Henry's costs compare to other urology physicians in Shenandoah?
Dr. Henry's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Henry) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Shenandoah
Browse urology physicians in Shenandoah ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology